Spectrophotometric determination of Atorvastatin Calcium in pharmaceutical by charge transfer complexation: التحديد الطيفي لأتورفاستاتين الكالسيوم في المستحضرات الصيدلانية عن طريق معقدات نقل الشحنة

Saad Antakli, Leon Nejem, Ahmad Kullah Saad Antakli, Leon Nejem, Ahmad Kullah
{"title":"Spectrophotometric determination of Atorvastatin Calcium in pharmaceutical by charge transfer complexation: التحديد الطيفي لأتورفاستاتين الكالسيوم في المستحضرات الصيدلانية عن طريق معقدات نقل الشحنة","authors":"Saad Antakli, Leon Nejem, Ahmad Kullah Saad Antakli, Leon Nejem, Ahmad Kullah","doi":"10.26389/ajsrp.n271021","DOIUrl":null,"url":null,"abstract":"  Rapid useful and easy spectrophotometric method for the quantitative analysis of (Atorvastatin calcium) (ATV) in raw material and tablets pharmaceutical formulation has been described. This method is based on the formation of yellow ion-pair complex between Atorvastatin calcium and Bromocresol purple (BCP) in Dichloromethane medium.   Different parameters affecting the reaction such as: effect of solvents, stability, reagent concentration, correlation ratio, etc. were optimized. The absorbance of the formed compound was measured by visible spectrum at absorption maximum 405 nm. The range of linearity was 3.02 – 42.33 µg/mL, , regression analysis had a good correlation coefficient R2 = 0.9994. The limit of detection (LOD) and limit of quantification (LOQ) were to be 0.463 µg/mL and 1.403 µg/mL respectively. The (average percent recovery) was found to be (99.26 – 99.85) % for (Atorvastatin Calcium). This study was applied on Syrian pharmaceutical products: (Atoraz 20 mg & Atoraz 40 mg). The method was successfully applied for the determination of Atorvastatin calcium in tablets pharmaceutical formulation. The proposed method is simple, direct, sensitive doesn’t require any )extraction(  process. Thus, the method could be ready to apply in routine analysis and quality control.","PeriodicalId":16473,"journal":{"name":"Journal of natural sciences, life and applied sciences","volume":"143 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of natural sciences, life and applied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26389/ajsrp.n271021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

  Rapid useful and easy spectrophotometric method for the quantitative analysis of (Atorvastatin calcium) (ATV) in raw material and tablets pharmaceutical formulation has been described. This method is based on the formation of yellow ion-pair complex between Atorvastatin calcium and Bromocresol purple (BCP) in Dichloromethane medium.   Different parameters affecting the reaction such as: effect of solvents, stability, reagent concentration, correlation ratio, etc. were optimized. The absorbance of the formed compound was measured by visible spectrum at absorption maximum 405 nm. The range of linearity was 3.02 – 42.33 µg/mL, , regression analysis had a good correlation coefficient R2 = 0.9994. The limit of detection (LOD) and limit of quantification (LOQ) were to be 0.463 µg/mL and 1.403 µg/mL respectively. The (average percent recovery) was found to be (99.26 – 99.85) % for (Atorvastatin Calcium). This study was applied on Syrian pharmaceutical products: (Atoraz 20 mg & Atoraz 40 mg). The method was successfully applied for the determination of Atorvastatin calcium in tablets pharmaceutical formulation. The proposed method is simple, direct, sensitive doesn’t require any )extraction(  process. Thus, the method could be ready to apply in routine analysis and quality control.
干扰作用作用作用作用作用作用作用:通过托运合同对药品中钙酸的光谱测定
建立了一种快速、简便的测定原料药和片剂制剂中阿托伐他汀钙含量的分光光度法。该方法是基于阿托伐他汀钙与溴甲酚紫(BCP)在二氯甲烷介质中形成黄色离子对络合物。对溶剂、稳定性、试剂浓度、相关比等因素对反应的影响进行了优化。在最大吸收波长405 nm处用可见光谱测定了所合成化合物的吸光度。线性范围为3.02 ~ 42.33µg/mL,回归分析相关系数R2 = 0.9994。检测限(LOD)为0.463µg/mL,定量限(LOQ)为1.403µg/mL。阿托伐他汀钙的平均回收率为(99.26 ~ 99.85)%。本研究应用于叙利亚药品:(阿托拉兹20 mg和阿托拉兹40 mg)。该方法可用于片剂中阿托伐他汀钙的含量测定。该方法简单、直接、灵敏,不需要任何萃取过程。因此,该方法可用于常规分析和质量控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信